Christian Cruz, MD
Nephrology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Offices
- 2
- Since medical school
- 25 years
- Icahn School of Medicine at Mount Sinai, 2001
Offices
2 locations · West Coast Kidney · San Mateo Dialysis Associates
Hospitals listed: 052546 · 552642 · 752538 · Ahmc Seton Medical Center · California Pacific Medical Center - Mission Bernal · Mills-Peninsula Medical Center · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cruz’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A96754 · Current
Licensed to practise in California · since 2006 · expires 2027-12-31 · Mount Sinai School of Medicine of New York University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Peninsula dialysis access centerAmbulatory Surgery Center · South San Francisco, CA6% owner since 2024 · accredited by HFAPInitial Accreditation1 inspection, 1 with deficiencies · last 2025-07-29
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Nephrology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$564,028
Medicare paid this office $564,028 for 372 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 89 | $154,231 | $1,244 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 67 | $97,291 | $1,003 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 26 | $51,259 | $309 |
| Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment with review by radiologist | 11 | $49,267 | $4,479 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $20,240 | $104 |
See all 23 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 89 | $154,231 | $1,244 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 67 | $97,291 | $1,003 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 26 | $51,259 | $309 |
| Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment with review by radiologist | 11 | $49,267 | $4,479 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $20,240 | $104 |
| Critical care, first 30-74 minutes | 38 | $19,297 | $182 |
| Balloon dilation of dialysis segment with review by radiologist | 21 | $17,479 | $603 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 66 | $16,285 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 85 | $13,295 | $70 |
| Review by radiologist of arm or leg artery image | 70 | $12,881 | $145 |
| Long return visit (40+ min) | 35 | $12,837 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $9,633 | $144 |
| Return visit (30+ min) | 42 | $8,164 | $105 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 95 | $7,134 | $53 |
| Hemodialysis procedure with physician evaluation | 35 | $4,257 | $62 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 13 | $3,730 | $59 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 60 | $2,192 | $14 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 13 | $1,932 | $46 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 97 | $1,803 | $13 |
| Advance care planning, first 30 minutes | 11 | $1,057 | $70 |
| Advance care planning, first 30 minutes | 12 | $809 | $67 |
| Injection, fentanyl citrate, 0.1 mg | 72 | $63 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 101 | $16 | $0 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 188 | 254 | 188 | 159 | 151 | 124 |
| Balloon dilation of dialysis segment with review by radiologist | 70 | 92 | 96 | 66 | 55 | 29 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | – | – | – | 50 | 139 | 97 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | – | – | – | 48 | 139 | 96 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 33 | 47 | 12 | 16 | – | – |
| Insertion of tube into vein, second order branch | – | 43 | 24 | 21 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
372 Original Medicare patients in 2024. Average age 75 · Under 65 18% · 85 and older 21% · Women 47% · Also on Medicaid 46% · Health risk score 5.87. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 74% · Heart failure 62% · Coronary heart disease 56% · Atrial fibrillation 42% · Depression 26% · Dementia 23% · COPD 22% · Stroke 22% · Cancer 16%.
The office billed $1,527,313, Medicare allowed $716,355 and paid $564,028; for 2,376 services of 44 kinds; $79 of it was for drugs given in the office and $563,949 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 372 | 2,376 | 75 | 5.87 | $1,527,313 | $564,028 |
| 2023 | 379 | 2,483 | 75 | 5.75 | $1,881,230 | $706,198 |
| 2022 | 397 | 2,574 | 74 | 5.42 | $1,751,216 | $658,404 |
| 2021 | 423 | 2,829 | 73 | 5.80 | $1,822,951 | $714,348 |
| 2020 | 499 | 3,772 | 74 | 6.02 | $2,792,123 | $1,056,921 |
| 2019 | 480 | 2,576 | 74 | 6.03 | $1,753,587 | $678,153 |
| 2018 | 519 | 2,674 | 74 | 6.17 | $2,194,446 | $751,096 |
| 2017 | 519 | 2,840 | 73 | 6.06 | $2,046,437 | $619,759 |
| 2016 | 452 | 2,708 | 74 | 5.36 | $2,305,279 | $612,287 |
| 2015 | 415 | 2,466 | 75 | 5.31 | $2,217,517 | $576,125 |
| 2014 | 466 | 2,753 | 74 | 5.31 | $2,632,327 | $702,145 |
| 2013 | 462 | 2,641 | 73 | 5.25 | $2,517,256 | $685,041 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 105 | $190,062 | $1,259 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 89 | $142,043 | $1,022 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 37 | $61,427 | $323 |
| Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment with review by radiologist | 12 | $55,842 | $4,653 |
| Balloon dilation of dialysis segment with review by radiologist | 37 | $33,870 | $616 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $25,039 | $106 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 89 | $23,518 | $169 |
| Review by radiologist of arm or leg artery image | 99 | $19,842 | $145 |
| Critical care, first 30-74 minutes | 40 | $18,387 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $9,615 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $9,044 | $71 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 108 | $8,549 | $52 |
| Return visit (30+ min) | 50 | $8,410 | $74 |
| Long return visit (40+ min) | 35 | $6,483 | $88 |
| Hemodialysis procedure with physician evaluation | 38 | $3,099 | $65 |
| New patient visit (60+ min) | 14 | $2,868 | $205 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 115 | $2,206 | $12 |
| Removal of tunneled central venous tube | 12 | $1,543 | $129 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $922 | $54 |
| Injection, fentanyl citrate, 0.1 mg | 103 | $113 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 120 | $22 | $0 |
2022: 26 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 107 | $207,614 | $1,306 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $58,008 | $322 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 40 | $52,773 | $1,055 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 15 | $44,816 | $2,490 |
| Balloon dilation of dialysis segment with review by radiologist | 40 | $42,016 | $637 |
| Review by radiologist of arm or leg artery image | 102 | $23,610 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 105 | $20,148 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $15,061 | $92 |
| Critical care, first 30-74 minutes | 41 | $14,815 | $188 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 15 | $11,522 | $720 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $9,811 | $273 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 116 | $9,779 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,763 | $171 |
| Insertion of tube into vein, second order branch | 14 | $9,533 | $454 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 38 | $8,099 | $169 |
| Return visit (30+ min) | 52 | $6,298 | $56 |
| Long return visit (40+ min) | 34 | $4,526 | $73 |
| Hemodialysis procedure with physician evaluation | 35 | $3,473 | $66 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 121 | $2,349 | $12 |
| Removal of tunneled central venous tube | 15 | $2,288 | $153 |
| Ultrasound study of arm and leg arteries | 15 | $1,302 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,301 | $57 |
| Hemodialysis procedure requiring repeated evaluation | 12 | $1,211 | $93 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 16 | $393 | $11 |
| Injection, fentanyl citrate, 0.1 mg | 98 | $98 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 124 | $20 | $0 |
2021: 23 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 126 | $260,581 | $1,386 |
| Balloon dilation of dialysis segment with review by radiologist | 64 | $67,883 | $707 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 44 | $60,712 | $326 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 12 | $39,284 | $2,619 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $24,553 | $63 |
| Review by radiologist of arm or leg artery image | 104 | $24,542 | $155 |
| Long return visit (40+ min) | 43 | $16,581 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $16,085 | $92 |
| Critical care, first 30-74 minutes | 31 | $15,588 | $195 |
| Insertion of tube into vein, second order branch | 19 | $11,435 | $476 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 133 | $11,377 | $54 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $10,862 | $272 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 12 | $9,276 | $773 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,221 | $174 |
| Hemodialysis procedure with physician evaluation | 65 | $8,412 | $64 |
| Return visit (30+ min) | 42 | $8,387 | $118 |
| New patient visit (60+ min) | 14 | $2,792 | $199 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 133 | $2,663 | $12 |
| Removal of tunneled central venous tube | 14 | $1,767 | $126 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,367 | $91 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 29 | $634 | $11 |
| Injection, fentanyl citrate, 0.1 mg | 119 | $98 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 141 | $21 | $0 |
2020: 26 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 148 | $339,561 | $1,337 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment and placement of stent with review by radiologist | 16 | $123,469 | $6,859 |
| Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment with review by radiologist | 12 | $77,926 | $5,566 |
| Balloon dilation of dialysis segment with review by radiologist | 58 | $66,660 | $725 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 73 | $55,911 | $255 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 17 | $55,324 | $2,515 |
| Review by radiologist of arm or leg artery image | 144 | $38,857 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 163 | $32,987 | $65 |
| Critical care, first 30-74 minutes | 48 | $25,476 | $197 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 42 | $23,567 | $501 |
| Insertion of tube into vein, second order branch | 28 | $20,256 | $471 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $19,933 | $183 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 162 | $16,426 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $12,348 | $96 |
| Hemodialysis procedure with physician evaluation | 84 | $11,047 | $66 |
| Return visit (30+ min) | 48 | $7,391 | $91 |
| Long return visit (40+ min) | 33 | $5,682 | $126 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 28 | $4,713 | $110 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $4,695 | $213 |
| Removal of tunneled central venous tube | 28 | $4,037 | $144 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 161 | $3,816 | $12 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $2,946 | $105 |
| Hemodialysis procedure requiring repeated evaluation | 15 | $1,541 | $96 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 45 | $1,253 | $11 |
| Injection, fentanyl citrate, 0.1 mg | 149 | $188 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 172 | $31 | $0 |
2019: 21 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 125 | $246,143 | $1,309 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 62 | $88,284 | $254 |
| Balloon dilation of dialysis segment with review by radiologist | 45 | $51,988 | $743 |
| Review by radiologist of arm or leg artery image | 111 | $26,305 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 139 | $25,240 | $65 |
| Critical care, first 30-74 minutes | 62 | $23,201 | $197 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $22,514 | $216 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 27 | $19,681 | $596 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $18,552 | $180 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 136 | $11,178 | $52 |
| Long return visit (40+ min) | 46 | $10,951 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $10,570 | $94 |
| Hemodialysis procedure with physician evaluation | 72 | $8,842 | $65 |
| Hemodialysis procedure requiring repeated evaluation | 22 | $3,291 | $94 |
| Return visit (30+ min) | 29 | $3,196 | $84 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $3,079 | $162 |
| New patient visit (60+ min) | 14 | $2,685 | $192 |
| Removal of tunneled central venous tube | 16 | $2,326 | $145 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 76 | $1,064 | $12 |
| Injection, fentanyl citrate, 0.1 mg | 60 | $47 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 62 | $7 | $0 |
2018: 19 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 138 | $262,737 | $1,245 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 62 | $69,156 | $252 |
| Balloon dilation of dialysis segment with review by radiologist | 41 | $48,860 | $752 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $36,159 | $64 |
| Review by radiologist of arm or leg artery image | 129 | $30,817 | $156 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 47 | $28,435 | $214 |
| Critical care, first 30-74 minutes | 57 | $22,910 | $194 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 26 | $17,394 | $580 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $17,042 | $176 |
| Hemodialysis procedure with physician evaluation | 98 | $13,182 | $64 |
| Insertion of tube into chest or arm artery, each first order branch | 20 | $13,170 | $507 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 154 | $12,781 | $51 |
| Insertion of tube into vein, second order branch | 20 | $11,925 | $442 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | $6,480 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,207 | $91 |
| Long return visit (40+ min) | 31 | $4,870 | $128 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 20 | $3,079 | $114 |
| Return visit (30+ min) | 32 | $2,770 | $71 |
| Removal of tunneled central venous tube | 17 | $2,102 | $124 |
2017: 19 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 104 | $190,768 | $1,215 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 68 | $73,013 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 217 | $61,823 | $64 |
| Critical care, first 30-74 minutes | 80 | $30,739 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $26,629 | $176 |
| Balloon dilation of dialysis segment with review by radiologist | 22 | $23,820 | $744 |
| Review by radiologist of arm or leg artery image | 99 | $22,201 | $157 |
| Hemodialysis procedure with physician evaluation | 115 | $18,434 | $64 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $17,523 | $216 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 31 | $16,744 | $540 |
| Insertion of tube into chest or arm artery, each first order branch | 17 | $11,321 | $566 |
| Insertion of tube into vein, second order branch | 14 | $8,837 | $442 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 111 | $7,967 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $6,333 | $93 |
| Return visit (30+ min) | 41 | $5,569 | $87 |
| Long return visit (40+ min) | 19 | $4,603 | $121 |
| Removal of tunneled central venous tube | 20 | $2,752 | $138 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 14 | $2,290 | $114 |
| New patient visit (60+ min) | 12 | $2,202 | $183 |
2016: 21 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 81 | $198,804 | $1,325 |
| Insertion of needle and/or catheter for dialysis | 101 | $70,232 | $453 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $44,431 | $255 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 192 | $39,079 | $63 |
| Critical care, first 30-74 minutes | 74 | $33,245 | $194 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 18 | $28,171 | $1,409 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 11 | $26,192 | $1,871 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $20,886 | $179 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 81 | $20,768 | $142 |
| Review by radiologist of arm or leg artery image | 82 | $18,529 | $163 |
| Hemodialysis procedure with physician evaluation | 84 | $13,070 | $63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 16 | $11,459 | $216 |
| Insertion of tube into vein, second order branch | 20 | $11,204 | $467 |
| Insertion of tube into chest or arm artery, each first order branch | 14 | $9,912 | $583 |
| Return visit (30+ min) | 62 | $7,955 | $86 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 22 | $6,844 | $274 |
| Long return visit (40+ min) | 25 | $6,598 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $4,551 | $93 |
| Dialysis procedure including 1 evaluation | 13 | $4,166 | $79 |
| Radiological supervision and interpretation of balloon dilation of narrowed artery | 19 | $3,046 | $145 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 19 | $2,691 | $117 |
2015: 19 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 80 | $185,535 | $1,288 |
| Insertion of needle and/or catheter for dialysis | 96 | $67,819 | $443 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $31,267 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 189 | $30,714 | $65 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 15 | $29,777 | $1,567 |
| Critical care, first 30-74 minutes | 54 | $26,775 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $23,301 | $179 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 81 | $20,360 | $139 |
| Review by radiologist of arm or leg artery image | 82 | $18,734 | $159 |
| Insertion of tube into chest or arm artery, each first order branch | 25 | $18,694 | $584 |
| Insertion of tube into vein, second order branch | 24 | $15,698 | $462 |
| Hemodialysis procedure with physician evaluation | 81 | $14,844 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $9,505 | $216 |
| Return visit (30+ min) | 52 | $7,828 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,228 | $93 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 24 | $4,076 | $116 |
| Long return visit (40+ min) | 17 | $3,334 | $111 |
| Dialysis procedure including 1 evaluation | 14 | $2,972 | $78 |
| Radiological supervision and interpretation of balloon dilation of narrowed artery | 14 | $2,571 | $143 |
2014: 22 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 95 | $218,267 | $1,323 |
| Insertion of needle and/or catheter for dialysis | 119 | $87,839 | $465 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 19 | $51,698 | $1,915 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 19 | $36,600 | $1,464 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 210 | $34,481 | $64 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $31,335 | $255 |
| Insertion of tube into chest or arm artery, each first order branch | 30 | $24,830 | $591 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 95 | $24,333 | $149 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $23,745 | $180 |
| Critical care, first 30-74 minutes | 51 | $22,695 | $196 |
| Review by radiologist of arm or leg artery image | 81 | $19,502 | $176 |
| Insertion of tube into vein, second order branch | 28 | $17,970 | $449 |
| Hemodialysis procedure with physician evaluation | 88 | $16,921 | $64 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 30 | $11,731 | $273 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $11,057 | $92 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $10,075 | $214 |
| Return visit (30+ min) | 57 | $8,233 | $90 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 28 | $5,017 | $125 |
| Radiological supervision and interpretation of balloon dilation of narrowed artery | 18 | $3,390 | $141 |
| Long return visit (40+ min) | 14 | $2,857 | $124 |
| Removal of tunneled central venous tube | 13 | $1,923 | $148 |
| Hemodialysis procedure requiring repeated evaluation | 14 | $1,766 | $93 |
2013: 24 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 85 | $225,855 | $1,344 |
| Insertion of needle and/or catheter for dialysis | 111 | $88,907 | $475 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 17 | $42,258 | $2,012 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 19 | $39,495 | $1,646 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $39,413 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 197 | $32,892 | $62 |
| Review by radiologist of arm or leg artery image | 95 | $26,032 | $182 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 85 | $25,894 | $154 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $21,798 | $172 |
| Hemodialysis procedure with physician evaluation | 87 | $15,806 | $62 |
| Insertion of tube into vein, second order branch | 27 | $15,315 | $464 |
| Insertion of tube into chest or arm artery, each first order branch | 20 | $13,961 | $635 |
| Critical care, first 30-74 minutes | 49 | $12,798 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $11,660 | $90 |
| Return visit (30+ min) | 59 | $8,318 | $88 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 23 | $8,228 | $284 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 11 | $5,376 | $215 |
| Long return visit (40+ min) | 19 | $4,555 | $120 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 27 | $4,318 | $131 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 15 | $4,236 | $81 |
| Radiological supervision and interpretation of balloon dilation of narrowed artery | 18 | $3,637 | $158 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,108 | $115 |
| Hemodialysis procedure requiring repeated evaluation | 28 | $2,981 | $90 |
| Removal of tunneled central venous tube | 11 | $1,365 | $124 |
Medicaid work
$148,122 in 2024
Medicaid paid $148,122 for 779 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| INTRO CATH DIALYSIS CIRCUIT | 87 | $71,278 |
| Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; initial noncoronary vessel (List separately in addition to code for primary procedure) | 60 | $47,798 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 87 | $10,022 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 80 | $8,922 |
| Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; each additional noncoronary vessel (List separately in addition to code for primary procedure) | 60 | $7,462 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 40 | $1,304 |
| Rhythm ECG, 1-3 leads; with interpretation and report | 119 | $1,134 |
| Fentanyl citrate injection | 83 | $181 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 163 | $20 |
| 2024 | 779 | 9 | 22 | $148,122 |
| 2023 | 785 | 11 | 25 | $156,722 |
| 2022 | 491 | 9 | 22 | $59,227 |
| 2021 | 928 | 11 | 27 | $90,684 |
| 2020 | 1,541 | 11 | 34 | $125,100 |
| 2019 | 1,014 | 10 | 40 | $86,736 |
| 2018 | 684 | 6 | 19 | $60,395 |
See the largest Medicaid services in earlier years
2023
| Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; initial noncoronary vessel (List separately in addition to code for primary procedure) | 79 | $64,004 |
| INTRO CATH DIALYSIS CIRCUIT | 84 | $54,237 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 110 | $18,647 |
| Intravascular ultrasound (noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation; each additional noncoronary vessel (List separately in addition to code for primary procedure) | 78 | $9,840 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 82 | $8,309 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $841 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $534 |
| Fentanyl citrate injection | 105 | $223 |
| Rhythm ECG, 1-3 leads; with interpretation and report | 33 | $73 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 146 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $0 |
2022
| INTRO CATH DIALYSIS CIRCUIT | 44 | $28,854 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 184 | $23,927 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 27 | $2,505 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 90 | $2,278 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $1,343 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 13 | $271 |
| Fentanyl citrate injection | 18 | $40 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 91 | $7 |
| Rhythm ECG, 1-3 leads; with interpretation and report | 12 | $2 |
2021
| INTRO CATH DIALYSIS CIRCUIT | 105 | $57,736 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 267 | $27,269 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 37 | $2,688 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 136 | $1,462 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 30 | $730 |
| Long return visit (40+ min) | 14 | $306 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 27 | $210 |
| Fentanyl citrate injection | 83 | $152 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 17 | $96 |
| Rhythm ECG, 1-3 leads; with interpretation and report | 26 | $23 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 186 | $12 |
2020
| INTRO CATH DIALYSIS CIRCUIT | 148 | $77,557 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 228 | $23,055 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 135 | $10,518 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 369 | $7,235 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 94 | $2,455 |
| 1ST HOSP IP/OBS HIGH 75 | 40 | $1,794 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 129 | $1,203 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $960 |
| Rhythm ECG, 1-3 leads; with interpretation and report | 93 | $198 |
| Fentanyl citrate injection | 67 | $112 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 217 | $12 |
2019
| INTRO CATH DIALYSIS CIRCUIT | 67 | $44,029 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 338 | $24,984 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 369 | $6,734 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 53 | $4,424 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 49 | $4,064 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 49 | $1,295 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $671 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 23 | $532 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 37 | $3 |
| Rhythm ECG, 1-3 leads; with interpretation and report | 14 | $0 |
2018
| INTRO CATH DIALYSIS CIRCUIT | 56 | $31,090 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 83 | $7,466 |
| Angiography, extremity, unilateral, radiological supervision and interpretation | 75 | $7,333 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 101 | $7,123 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 256 | $4,099 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 113 | $3,284 |
Drugs they prescribed that Part D paid
$233,216
Pharmacies billed $233,216 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 773) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
566 generic and fewer than 11 brand-name prescriptions · $233,216 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 84 | $102,169 | $1,216 |
| Jardiance | 22 | $29,486 | $1,340 |
| Sevelamer Carbonate | 19 | $7,774 | $409 |
| Prosol | 40 | $4,267 | $107 |
| Colchicine | 15 | $934 | $62 |
See all 17 drugs
| Farxiga | 84 | $102,169 | $1,216 |
| Jardiance | 22 | $29,486 | $1,340 |
| Sevelamer Carbonate | 19 | $7,774 | $409 |
| Prosol | 40 | $4,267 | $107 |
| Colchicine | 15 | $934 | $62 |
| Amlodipine Besylate | 97 | $642 | $7 |
| Losartan | 62 | $610 | $10 |
| Hydralazine | 42 | $485 | $12 |
| Olmesartan Medoxomil | 19 | $436 | $23 |
| Metoprolol | 16 | $389 | $24 |
| Allopurinol | 23 | $360 | $16 |
| Furosemide | 66 | $300 | $5 |
| Tamsulosin | 12 | $299 | $25 |
| Chlorthalidone | 18 | $263 | $15 |
| Lisinopril | 21 | $257 | $12 |
| Calcitriol | 15 | $143 | $10 |
| Prednisone | 17 | $87 | $5 |
Year by year
| 2024 | 773 | 140 | 0% (0) | None | $233,216 |
| 2023 | 609 | 118 | 0% (0) | 20% | $239,278 |
| 2022 | 593 | 110 | 0% (0) | 17% | $145,922 |
| 2021 | 599 | 115 | 0% (0) | 19% | $115,502 |
| 2020 | 466 | 86 | 0% (0) | 23% | $63,855 |
| 2019 | 545 | 92 | 0% (0) | 32% | $85,191 |
| 2018 | 724 | 106 | None | 38% | $124,317 |
| 2017 | 806 | 117 | None | 30% | $188,924 |
| 2016 | 855 | 108 | None | None | $203,937 |
| 2015 | 850 | 101 | None | 34% | $187,195 |
| 2014 | 916 | 106 | None | 37% | $195,779 |
| 2013 | 878 | 108 | None | 32% | $136,538 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Farxiga | 55 | $85,073 | $1,547 |
| Velphoro | 16 | $75,656 | $4,729 |
| Sevelamer Carbonate | 12 | $3,770 | $314 |
| Prosol | 23 | $3,048 | $133 |
| Losartan | 55 | $1,491 | $27 |
| Hydralazine | 45 | $1,298 | $29 |
| Amlodipine Besylate | 83 | $1,112 | $13 |
| Allopurinol | 28 | $533 | $19 |
| Metoprolol | 18 | $490 | $27 |
| Furosemide | 32 | $461 | $14 |
| Tamsulosin | 12 | $240 | $20 |
| Calcitriol | 22 | $222 | $10 |
| Lisinopril | 25 | $204 | $8 |
| Prednisone | 20 | $97 | $5 |
| Hydrochlorothiazide | 13 | $70 | $5 |
2022: 15 drugs
| Farxiga | 65 | $77,082 | $1,186 |
| Velphoro | 15 | $27,380 | $1,825 |
| Clinisol | 29 | $4,090 | $141 |
| Sevelamer Carbonate | 14 | $1,959 | $140 |
| Losartan | 61 | $1,081 | $18 |
| Hydralazine | 29 | $905 | $31 |
| Amlodipine Besylate | 73 | $704 | $10 |
| Chlorthalidone | 18 | $571 | $32 |
| Valsartan | 11 | $473 | $43 |
| Allopurinol | 22 | $458 | $21 |
| Furosemide | 24 | $315 | $13 |
| Calcitriol | 27 | $189 | $7 |
| Tamsulosin | 26 | $178 | $7 |
| Lisinopril | 31 | $174 | $6 |
| Prednisone | 30 | $157 | $5 |
2021: 14 drugs
| Velphoro | 19 | $37,182 | $1,957 |
| Farxiga | 42 | $27,395 | $652 |
| Sevelamer Carbonate | 33 | $14,767 | $447 |
| Hydralazine | 66 | $1,165 | $18 |
| Amlodipine Besylate | 66 | $888 | $13 |
| Losartan | 52 | $829 | $16 |
| Metoprolol | 20 | $475 | $24 |
| Valsartan | 11 | $378 | $34 |
| Allopurinol | 26 | $362 | $14 |
| Furosemide | 30 | $262 | $9 |
| Tamsulosin | 17 | $126 | $7 |
| Prednisone | 28 | $91 | $3 |
| Lisinopril | 20 | $69 | $3 |
| Hydrochlorothiazide | 12 | $66 | $6 |
2020: 12 drugs
| Intralipid | 28 | $5,306 | $189 |
| Clinolipid | 27 | $5,281 | $196 |
| Sevelamer Carbonate | 19 | $4,168 | $219 |
| Losartan | 52 | $744 | $14 |
| Amlodipine Besylate | 58 | $576 | $10 |
| Chlorthalidone | 14 | $390 | $28 |
| Furosemide | 34 | $359 | $11 |
| Hydralazine | 23 | $283 | $12 |
| Allopurinol | 12 | $181 | $15 |
| Lisinopril | 23 | $154 | $7 |
| Torsemide | 15 | $140 | $9 |
| Prednisone | 21 | $71 | $3 |
2019: 12 drugs
| Intralipid | 76 | $17,521 | $231 |
| Sevelamer Carbonate | 18 | $6,011 | $334 |
| Prosol | 40 | $5,617 | $140 |
| Losartan | 61 | $1,035 | $17 |
| Chlorthalidone | 23 | $588 | $26 |
| Amlodipine Besylate | 42 | $397 | $9 |
| Furosemide | 47 | $235 | $5 |
| Allopurinol | 16 | $232 | $15 |
| Hydralazine | 15 | $171 | $11 |
| Lisinopril | 37 | $168 | $5 |
| Gabapentin | 11 | $87 | $8 |
| Prednisone | 15 | $34 | $2 |
2018: 15 drugs
| Renvela | 24 | $36,472 | $1,520 |
| Sevelamer Carbonate | 50 | $28,793 | $576 |
| Intralipid | 95 | $20,880 | $220 |
| Prosol | 78 | $12,498 | $160 |
| Labetalol | 15 | $636 | $42 |
| Losartan | 55 | $500 | $9 |
| Chlorthalidone | 11 | $436 | $40 |
| Benazepril | 19 | $292 | $15 |
| Amlodipine Besylate | 64 | $286 | $4 |
| Allopurinol | 24 | $256 | $11 |
| Atorvastatin | 12 | $251 | $21 |
| Hydralazine | 18 | $178 | $10 |
| Lisinopril | 45 | $158 | $4 |
| Furosemide | 18 | $81 | $4 |
| Prednisone | 15 | $30 | $2 |
2017: 23 drugs
| Renvela | 61 | $104,003 | $1,705 |
| Sensipar | 16 | $26,088 | $1,630 |
| Prosol | 88 | $20,841 | $237 |
| Sevelamer Carbonate | 12 | $11,986 | $999 |
| Intralipid | 15 | $3,368 | $225 |
| Calcium Acetate | 19 | $1,614 | $85 |
| Labetalol | 20 | $562 | $28 |
| Losartan | 61 | $561 | $9 |
| Amlodipine Besylate | 98 | $385 | $4 |
| Valsartan | 13 | $326 | $25 |
| Hydralazine | 27 | $277 | $10 |
| Benazepril | 22 | $257 | $12 |
| Levothyroxine | 17 | $252 | $15 |
| Allopurinol | 16 | $207 | $13 |
| Atorvastatin | 13 | $174 | $13 |
| Lisinopril | 46 | $156 | $3 |
| Gabapentin | 17 | $101 | $6 |
| Furosemide | 29 | $96 | $3 |
| Simvastatin | 18 | $82 | $5 |
| Pantoprazole | 12 | $69 | $6 |
| Metoprolol | 23 | $60 | $3 |
| Carvedilol | 11 | $59 | $5 |
| Famotidine | 17 | $24 | $1 |
2016: 20 drugs
| Renvela | 45 | $74,661 | $1,659 |
| Sensipar | 31 | $52,733 | $1,701 |
| Prosol | 102 | $23,928 | $235 |
| Dextrose in Water | 29 | $8,795 | $303 |
| Uloric | 12 | $3,415 | $285 |
| Calcium Acetate | 13 | $1,853 | $143 |
| Doxazosin Mesylate | 18 | $1,109 | $62 |
| Valsartan | 19 | $1,001 | $53 |
| Nateglinide | 12 | $761 | $63 |
| Metoprolol | 21 | $587 | $28 |
| Amlodipine Besylate | 95 | $429 | $5 |
| Losartan | 55 | $415 | $8 |
| Hydralazine | 26 | $388 | $15 |
| Levothyroxine | 17 | $314 | $18 |
| Atorvastatin | 18 | $299 | $17 |
| Calcitriol | 14 | $245 | $17 |
| Lisinopril | 60 | $238 | $4 |
| Benazepril | 16 | $174 | $11 |
| Furosemide | 38 | $105 | $3 |
| Simvastatin | 16 | $63 | $4 |
2015: 17 drugs
| Renvela | 74 | $93,557 | $1,264 |
| Sensipar | 21 | $25,796 | $1,228 |
| Prosol | 96 | $24,682 | $257 |
| Fosrenol | 21 | $17,749 | $845 |
| Doxazosin Mesylate | 12 | $731 | $61 |
| Lisinopril | 133 | $604 | $5 |
| Metoprolol | 18 | $576 | $32 |
| Losartan | 58 | $426 | $7 |
| Amlodipine Besylate | 70 | $350 | $5 |
| Allopurinol | 18 | $231 | $13 |
| Hydralazine | 21 | $200 | $10 |
| Benazepril | 20 | $168 | $8 |
| Furosemide | 41 | $120 | $3 |
| Pantoprazole | 12 | $90 | $7 |
| Sertraline | 15 | $89 | $6 |
| Simvastatin | 13 | $86 | $7 |
| Zolpidem | 11 | $19 | $2 |
2014: 25 drugs
| Renvela | 117 | $121,460 | $1,038 |
| Sensipar | 17 | $20,147 | $1,185 |
| Prosol | 67 | $17,658 | $264 |
| Fosrenol | 11 | $8,728 | $793 |
| Lovaza | 15 | $3,517 | $234 |
| Intralipid | 17 | $3,432 | $202 |
| Lantus | 12 | $2,633 | $219 |
| Losartan | 37 | $1,072 | $29 |
| Potassium Chloride | 15 | $595 | $40 |
| Amlodipine Besylate | 77 | $555 | $7 |
| Dextrose in Water | 13 | $553 | $43 |
| Lisinopril | 92 | $432 | $5 |
| Spironolactone | 12 | $331 | $28 |
| Lidocaine-Prilocaine | 13 | $262 | $20 |
| Gabapentin | 15 | $211 | $14 |
| Zolpidem | 20 | $202 | $10 |
| Isosorbide Mononitrate Er | 18 | $200 | $11 |
| Simvastatin | 17 | $183 | $11 |
| Clonidine | 25 | $179 | $7 |
| Allopurinol | 28 | $151 | $5 |
| Hydralazine | 13 | $139 | $11 |
| Clopidogrel | 11 | $94 | $9 |
| Furosemide | 21 | $89 | $4 |
| Carvedilol | 12 | $83 | $7 |
| Sertraline | 13 | $52 | $4 |
2013: 22 drugs
| Renvela | 85 | $70,287 | $827 |
| Sensipar | 22 | $26,997 | $1,227 |
| Fosrenol | 11 | $9,416 | $856 |
| Intralipid | 37 | $6,041 | $163 |
| Clonidine | 31 | $3,573 | $115 |
| Lantus | 14 | $2,158 | $154 |
| Nifedipine Er | 18 | $1,427 | $79 |
| Losartan | 45 | $1,084 | $24 |
| Potassium Chloride | 11 | $654 | $59 |
| Lisinopril | 90 | $575 | $6 |
| Amlodipine Besylate | 74 | $494 | $7 |
| Lidocaine-Prilocaine | 18 | $427 | $24 |
| Torsemide | 12 | $404 | $34 |
| Tamsulosin | 16 | $297 | $19 |
| Clonidine | 30 | $265 | $9 |
| Allopurinol | 35 | $213 | $6 |
| Simvastatin | 22 | $174 | $8 |
| Furosemide | 42 | $134 | $3 |
| Metoprolol | 20 | $105 | $5 |
| Glipizide | 14 | $80 | $6 |
| Sertraline | 12 | $60 | $5 |
| Zolpidem | 13 | $51 | $4 |
Money from drug and device companies
$1,065 in 2025
| 2025 | 14 | 35 | None | $1,065 |
| 2024 | 13 | 35 | None | $15,806 |
| 2023 | 8 | 12 | None | $15,379 |
| 2022 | 5 | 29 | None | $15,406 |
| 2021 | 8 | 26 | None | $17,273 |
| 2020 | 4 | 11 | None | $215 |
| 2019 | 4 | 18 | None | $331 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Fabhalta | $223 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $166 | 6 payments
|
| Novo Nordisk | Wegovy | $136 | 2 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $97 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $89 | 3 payments
|
| Calliditas Therapeutics US | Tarpeyo | $73 | 2 payments
|
See all 35 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Fabhalta | $33 |
| ANI Pharmaceuticals | Meals · 2025-12-11 | Purified Cortrophin Gel | $29 |
| Apellis Pharmaceuticals | Meals · 2025-12-09 | Empaveli | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-13 | Kerendia | $24 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Fabhalta | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-22 | Lokelma | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-10 | Jardiance | $25 |
| Novartis Pharmaceuticals | Meals · 2025-10-02 | Fabhalta | $32 |
| Mallinckrodt Hospital Products | Meals · 2025-09-24 | Acthar | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-19 | Vanrafia | $25 |
| Novartis Pharmaceuticals | Meals · 2025-09-16 | Fabhalta | $26 |
| Otsuka America Pharmaceutical | Meals · 2025-09-11 | Jynarque | $17 |
| ANI Pharmaceuticals | Meals · 2025-08-14 | Purified Cortrophin Gel | $35 |
| Otsuka America Pharmaceutical | Meals · 2025-08-05 | Jynarque | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-23 | Farxiga | $23 |
| Scpharmaceuticals | Meals · 2025-06-24 | Furoscix | $25 |
| Ardelyx | Meals · 2025-06-05 | Ibsrela | $28 |
| Amgen | Meals · 2025-05-30 | Tavneos | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-16 | Kerendia | $34 |
| Calliditas Therapeutics US | Meals · 2025-05-16 | Tarpeyo | $37 |
| Novo Nordisk | Meals · 2025-05-14 | Wegovy | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-09 | Lokelma | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-05-02 | Acthar | $36 |
| Novartis Pharmaceuticals | Meals · 2025-03-28 | Fabhalta | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-25 | Farxiga | $31 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-14 | None | $27 |
| ANI Pharmaceuticals | Meals · 2025-03-13 | Purified Cortrophin Gel | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-12 | Farxiga | $29 |
| Novo Nordisk | Meals · 2025-02-24 | Wegovy | $122 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $32 |
| Novartis Pharmaceuticals | Meals · 2025-02-07 | Fabhalta | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-25 | Farxiga | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-01-17 | Jynarque | $23 |
| Calliditas Therapeutics US | Meals · 2025-01-16 | Tarpeyo | $36 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Fabhalta | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $15,806
| AngioDynamics | Auryon Laser System 100-120 Vac | $15,000 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $266 | 11 payments
|
| Novartis Pharmaceuticals | Fabhalta | $124 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $73 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $62 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $53 | 2 payments
|
| Lilly USA | Jardiance | $51 | 2 payments
|
| Travere Therapeutics | None | $35 | 1 payment
|
| Vifor Pharma | Veltassa | $31 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $30 | 2 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $29 | 1 payment
|
| Amgen | Krystexxa | $29 | 2 payments
|
| OPKO Pharmaceuticals | Rayaldee | $24 | 1 payment
|
2023: $15,379
| AngioDynamics | Auryon Laser System 100-120 Vac | $15,000 | 1 payment
|
| Amgen | Aranesp | $204 | 3 payments
|
| Boston Scientific | None | $65 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $24 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $23 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
2022: $15,406
| AngioDynamics | Auryon Laser System 100-120 Vac | $15,000 | 1 payment
|
| Boston Scientific | General - Ultrasound | $346 | 24 payments
|
| OPKO Pharmaceuticals | Rayaldee | $35 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $13 | 1 payment
|
| Amgen | Parsabiv | $11 | 1 payment
|
2021: $17,273
| AngioDynamics | Auryon Laser System 100-120 Vac | $16,750 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $154 | 7 payments
|
| Amgen | Parsabiv | $119 | 5 payments
|
| Fresenius USA Marketing | Velphoro | $115 | 6 payments
|
| Vifor Pharma | Veltassa | $64 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $42 | 2 payments
|
| Boston Scientific | General Ultrasound | $16 | 1 payment
|
| Daiichi Sankyo | Injectafer | $13 | 1 payment
|
2020: $215
| Otsuka America Pharmaceutical | Jynarque | $77 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $72 | 4 payments
|
| Amgen | Parsabiv | $46 | 2 payments
|
| Relypsa | Veltassa | $20 | 1 payment
|
2019: $331
| Amgen | Parsabiv | $130 | 6 payments
|
| Relypsa | Veltassa | $89 | 5 payments
|
| Janssen Pharmaceuticals | Invokana | $87 | 5 payments
|
| Bard Peripheral Vascular | Covera | $25 | 2 payments
|
Professional record
- NPI
- 1023182227
- Licence
- CA A96754California A96754: Current · expires 2027-12-31
- Trained
- Icahn School of Medicine at Mount Sinai, 2001 · 25 years ago
- Group
- West Coast Kidney · San Mateo Dialysis Associates
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 1023182227
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2149 E Warner Rd Ste 102, Tempe, AZ, 85284
- NPI first listed
- 2006-11-20
- NPI last updated
- 2019-08-26
This is when the NPI record was last certified, not a medical board exam.